KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,394,000 | +68.6% | 998,823 | +86.4% | 0.00% | 0.0% |
| Q2 2018 | $2,013,000 | +61.7% | 535,791 | +75.8% | 0.00% | 0.0% |
| Q1 2018 | $1,245,000 | +30.2% | 304,722 | +48.0% | 0.00% | 0.0% |
| Q4 2017 | $956,000 | +33.1% | 205,933 | +103.2% | 0.00% | – |
| Q3 2017 | $718,000 | +1.1% | 101,348 | +3.0% | 0.00% | -100.0% |
| Q2 2017 | $710,000 | +400.0% | 98,376 | +321.4% | 0.00% | – |
| Q1 2017 | $142,000 | -59.8% | 23,344 | -61.4% | 0.00% | – |
| Q4 2016 | $353,000 | -59.6% | 60,505 | -63.3% | 0.00% | -100.0% |
| Q3 2016 | $873,000 | -14.6% | 164,862 | +6.6% | 0.00% | 0.0% |
| Q2 2016 | $1,022,000 | +942.9% | 154,695 | +623.6% | 0.00% | – |
| Q1 2016 | $98,000 | -59.2% | 21,379 | -55.4% | 0.00% | – |
| Q4 2015 | $240,000 | -80.1% | 47,973 | -86.0% | 0.00% | -100.0% |
| Q3 2015 | $1,205,000 | -30.3% | 342,802 | +97.6% | 0.00% | 0.0% |
| Q2 2015 | $1,728,000 | +99.1% | 173,503 | +153.5% | 0.00% | 0.0% |
| Q1 2015 | $868,000 | -72.3% | 68,435 | -69.1% | 0.00% | -50.0% |
| Q4 2014 | $3,129,000 | -6.9% | 221,387 | -9.6% | 0.00% | 0.0% |
| Q3 2014 | $3,361,000 | +267.7% | 244,776 | +310.7% | 0.00% | +100.0% |
| Q2 2014 | $914,000 | -27.3% | 59,595 | -19.3% | 0.00% | 0.0% |
| Q1 2014 | $1,258,000 | +11.4% | 73,865 | -15.4% | 0.00% | 0.0% |
| Q4 2013 | $1,129,000 | -87.7% | 87,337 | -90.4% | 0.00% | -85.7% |
| Q3 2013 | $9,182,000 | – | 910,195 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |